296 related articles for article (PubMed ID: 28490271)
1. Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.
Pandya A; Sy S; Cho S; Alam S; Weinstein MC; Gaziano TA
Med Decis Making; 2017 Oct; 37(7):802-814. PubMed ID: 28490271
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of the US Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model: Health Disparity and Economic Impact Model.
Kim DD; Wang L; Lauren BN; Liu J; Marklund M; Lee Y; Micha R; Mozaffarian D; Wong JB
Med Decis Making; 2023; 43(7-8):930-948. PubMed ID: 37842820
[TBL] [Abstract][Full Text] [Related]
3. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
[TBL] [Abstract][Full Text] [Related]
4. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
5. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines.
Pandya A; Weinstein MC; Salomon JA; Cutler D; Gaziano TA
Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):25-32. PubMed ID: 24425701
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study.
Lee Y; Mozaffarian D; Sy S; Huang Y; Liu J; Wilde PE; Abrahams-Gessel S; Jardim TSV; Gaziano TA; Micha R
PLoS Med; 2019 Mar; 16(3):e1002761. PubMed ID: 30889188
[TBL] [Abstract][Full Text] [Related]
7. Predictive Validity of the American College of Cardiology/American Heart Association Pooled Cohort Equations in Predicting All-Cause and Cardiovascular Disease-Specific Mortality in a National Prospective Cohort Study of Adults in the United States.
Loprinzi PD; Addoh O
Mayo Clin Proc; 2016 Jun; 91(6):763-9. PubMed ID: 27180122
[TBL] [Abstract][Full Text] [Related]
8. Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?
Ortendahl JD; Diamant AL; Toth PP; Cherepanov D; Harmon AL; Broder MS
Clin Cardiol; 2019 Jan; 42(1):47-55. PubMed ID: 30318600
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project.
Hata J; Nagai A; Hirata M; Kamatani Y; Tamakoshi A; Yamagata Z; Muto K; Matsuda K; Kubo M; Nakamura Y; ; Kiyohara Y; Ninomiya T
J Epidemiol; 2017 Mar; 27(3S):S71-S76. PubMed ID: 28142037
[TBL] [Abstract][Full Text] [Related]
10. An Electrocardiogram-Based Risk Equation for Incident Cardiovascular Disease From the National Health and Nutrition Examination Survey.
Shah AJ; Vaccarino V; Janssens AC; Flanders WD; Kundu S; Veledar E; Wilson PW; Soliman EZ
JAMA Cardiol; 2016 Oct; 1(7):779-786. PubMed ID: 27487404
[TBL] [Abstract][Full Text] [Related]
11. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
[TBL] [Abstract][Full Text] [Related]
12. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
[TBL] [Abstract][Full Text] [Related]
14. Is outdoor recreational activity an independent predictor of cardiovascular disease mortality - NHANES III?
Donneyong MM; Taylor KC; Kerber RA; Hornung CA; Scragg R
Nutr Metab Cardiovasc Dis; 2016 Aug; 26(8):735-42. PubMed ID: 27089974
[TBL] [Abstract][Full Text] [Related]
15. The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States.
Qureshi AI; Suri MF; Kirmani JF; Divani AA
Stroke; 2004 Oct; 35(10):2346-50. PubMed ID: 15345797
[TBL] [Abstract][Full Text] [Related]
16. The impact of prevention on reducing the burden of cardiovascular disease.
Kahn R; Robertson RM; Smith R; Eddy D
Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
[TBL] [Abstract][Full Text] [Related]
17. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cardiovascular risk in patients with chronic obstructive pulmonary disease: a study of the National Health and Nutrition Examination Survey database.
Shi Y; Zhang J; Huang Y
BMC Cardiovasc Disord; 2021 Sep; 21(1):417. PubMed ID: 34470611
[TBL] [Abstract][Full Text] [Related]
19. Association of lipid accumulation product with all-cause and cardiovascular disease mortality: Result from NHANES database.
Chen S; Luo M; Sheng Z; Zhou R; Xiang W; Huang W; Shen Y
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1467-1476. PubMed ID: 38555243
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.
Battes L; Barendse R; Steyerberg EW; Simoons ML; Deckers JW; Nieboer D; Bertrand M; Ferrari R; Remme WJ; Fox K; Takkenberg JJ; Boersma E; Kardys I
Am J Cardiol; 2013 Jul; 112(1):27-33. PubMed ID: 23558041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
